BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Toyoda Gosei to Begin Collaboration With EBM Corporation in Developing Surgical Training Simulators Using e-Rubber

  Toyoda Gosei decided to work with EBM in order to achieve more life-like simulators by combining Toyoda Gosei’s e-Rubber technology.

  November 8, 2017

   · 

  2 min read
• Business

  Stephens & Associates Appoints an Internationally Recognized Dermatologist and a Senior Skin Scientist/Entrepreneur to Lead its New Phoenix Clinical Research Facility

  Stephens & Associates announces the appointment of Mark V. Dahl, MD, and Lawrence A. Rheins, PhD, to lead its newly-opened Phoenix research facility.

  November 8, 2017

   · 

  3 min read
• Business

  Merrimack Reports Third Quarter 2017 Financial Results

  Merrimack today announced its third quarter 2017 financial results for the period ended September 30, 2017.

  November 8, 2017

   · 

  17 min read
• Business

  Eagle Pharmaceuticals Reports Third Quarter 2017 Results

  Total revenue for the third quarter of 2017 grew 67% to $63.0 million compared to $37.8 million in the third quarter of 2016.

  November 8, 2017

   · 

  19 min read
• Medivir Announces New Cancer Project, Leukotide, Derived From Its In-House Nucleotide Platform

  The Leukotide project is intended to deliver a new drug for the treatment of AML and other hematological malignancies, and is based on the company’s expertise in nucleoside and nucleotide science.

  November 8, 2017

   · 

  2 min read
• FDA

  Chugai’s ALK Inhibitor “Alecensa” Approved for the Treatment of First Line Therapy on ALK-Positive Non-Small Cell Lung Cancer in the US

  Chugai Pharmaceutical announced today that Genentech, a member of the Roche Group, obtained approval from the U.S. FDA, for Alecensa in the treatment of “anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer”.

  November 8, 2017

   · 

  5 min read
• 

  Deals

  German Biotech InflaRx Snags $100M in IPO

  The company announced the pricing of its initial public offering of 6,667,000 common shares at an initial public offering price of $15.00 per common share.

  November 8, 2017

   · 

  2 min read
• Business

  Evotec AG Announces First Nine-Month 2017 Results and Corporate Update

  In the first nine months of 2017, Evotec’s Group revenues grew to EUR 170.9 m, an increase of 42% compared to the same period of 2016 (9M 2016: EUR 120.6 m).

  November 8, 2017

   · 

  16 min read
• Business

  Egalet Announces Third Quarter 2017 Financial Results

  Egalet today announced financial results for the third quarter ended September 30, 2017.

  November 8, 2017

   · 

  18 min read
• Business

  Bracket Strengthens Global Growth and Development Strategy With New CCO, Christopher Crucitti

  Crucitti joins Bracket as an experienced commercial leader in clinical and R&D services.

  November 8, 2017

   · 

  3 min read